SCHEMBL1798765

SCHEMBL1798765

O=C(CCCCNC(=O)Nc1ccc(Cl)cc1)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 7/20 0.51
GRIK1 P39086 2/20 0.51
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 1/20 0.50
FOLH1 Q04609 1/20 0.48
SLC6A3 Q01959 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
EPHX2 P34913 1/20 0.48
POLB P06746 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC10 Q969S8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1797318 0.89 ALDH1A1 (0.60) GRIK1KDM4EALDH1A1MAPTHDAC8
SCHEMBL1798425 0.88 EPHX2 (0.48) CNR1SLC6A3HDAC8EPHX2HDAC3
SCHEMBL1797445 0.78 ALDH1A1 (0.62) KDM4EALDH1A1MAPTHDAC3HDAC1
SCHEMBL8243576 0.77 HDAC1 (0.70) CNR1FOLH1SLC6A3HDAC8HDAC3
SCHEMBL15741900 0.77 FOLH1 (0.65) CNR1ALDH1A1FOLH1SLC6A3POLB
SCHEMBL11048686 0.76 CNR1 (0.70) CNR1SLC6A3NPC1RAB9ASMN1; SMN2
SCHEMBL1797245 0.76 ALDH1A1 (0.52) KDM4EALDH1A1MAPTHDAC8POLB
SCHEMBL1797569 0.75 SERPINE1 (0.56) GRIK1KDM4EALDH1A1MAPTPOLB
SCHEMBL418999 0.75 KDM4E (0.66) KDM4EALDH1A1MAPTPOLBHSD17B10
SCHEMBL539133 0.75 KDM4E (0.51) KDM4EALDH1A1MAPTPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US claimed
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 CNR1 3567/4885GRIK1 1873/4885KDM4E 4309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.